Go to main page RUS
WhatsApp, Viber, WeChat: +79269395956
Office: +74997023393
Email: info@medica-tour.ru
slide1.jpg Eye clinic Svjetlost.jpg Amber Life Cancer Clinic.jpg Treatment in Spain.jpg Treatment in India.jpg Treatment in Armenia big banner.jpg Organ transplantation (banner).jpg Stem cell therapy in Moscow.png Hair transplant in Turkey.jpg Fasting on Lake Baikal.png Plastic surgery in Moscow.png IVF in Moscow.png Cardiology in Moscow, Russia Childbirth in Canada.png

Agency of medical tourism and promotion of hospitals and resorts (Moscow, Russia)

MedicaTour Ltd. - agency of medical tourism and promotion of hospitals and resorts in Russia

MedicaTour Ltd. - is a team of professionals with 12 years of experience in the field of medical tourism and with more than 20 years of experience working in travel industry in general around the globe. In addition to sending patients from Russia and CIS for treatment abroad, the company offers services of promoting and PR of foreign hospitals in Russia and CIS.

The company MedicaTour cooperates with the ministries of various regions of Russia in developing of medical tourism. Third year the company is the official partner of the largest Russian state exhibition of medical tourism - MedTravelExpo.

Also, MedicaTour is official partner of the leading Russian medical TV channel "Doctor" and MedicaTour's CEO Tatiana Sokolov is an author and host of radio broadcast "Medical Tourism with Tatiana Sokolov" on Russian Radio 1.

Medical tourism, organization of treatment

MedicaTour is a serious professional with many years of experience in the field of medical tourism and one of the leading companies involved in the organization of treatment in different countries.
  • All areas of medicine
  • Both classic and innovative treatment methods
  • Major state medical centers and private clinics around the world
  • Selection of a medical institution for any budget

Read more here.

Promotion and PR of hospitals in Russia

In addition to sending patients from Russia and CIS for treatment abroad, the company offers services of promoting and PR of hospitals, clinics, medical centers, resorts and SPA hotels in Russia and CIS.

Experts of the company, based on excellent knowledge of the market, have developed special consulting packages, which are a list of services for marketing, PR and promotion. 

Read more here.

News All news
More than 80% of cancer cases are related to lifestyle and personal habits, and the prevention and correction of many of the factors causing the disease are possible and simple, says doctor Antonio Brugarolas, director of the oncology platform at Quirónsalud Torrevieja. The origin of cancer lies in the violation of the mechanism of cell regeneration and their control mechanisms, the appearance of the disease depends on a large number of different factors.
From 5 till 8.06, MedicaTour's General Director Tatiana Sokolov was invited to Seoul for the SITMMT-2019 medical tourism exhibition. 100 hosted buyers from different countries of the world were invited to the event to find new partners and to get acquainted with the possibilities of Korean medicine.
In recent years, an innovative approach to thyroid and parathyroid gland surgery, TOETVA, Transoral Endoscopic Thyroidectomy, has been developed. This method is based on the access of the thyroid and parathyroid gland through the lower lip using conventional endoscopic equipment.
The most important thing in cells therapy for cirrhosis is to start treatment as soon as possible, as this gives a greater chance of restoring liver tissue. Treatment of liver cirrhosis with stem cells is based on their unique property — the ability to replace damaged tissue cells.
Individual pharmacotherapy specializes in the pharmacotherapeutic monitoring of oncological drugs, which provides for the determination of measures and the interpretation of indicators of the concentration of drugs in the blood in order to determine the effective and least toxic dosage of the drug for each patient.
Gene studies give us hope for curing chemotherapy-resistant tumors. All this is due to the use of DNA microarray technology, or, in other words, genetic analysis of tumors, which allows to determine in a clear and direct way a series consisting of 5 to 8 medications that can be used in treating each specific case of the disease, as well as a list of medications in relation to which the tumor is resistant.